Skip to main content

NextCure, Inc. (NXTC)

NASDAQ: NXTC · IEX Real-Time Price · USD
6.02 -0.18 (-2.90%)
Nov 26, 2021 1:00 PM EST - Market closed

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017
Net Income
-36.6-33.74-22.8-15.47
Depreciation & Amortization
3.412.691.680.58
Share-Based Compensation
7.911.890.260.08
Other Operating Activities
-19.68-6.4628.852.3
Operating Cash Flow
-44.95-35.627.99-12.51
Capital Expenditures
-7.13-3.37-3.06-8.65
Change in Investments
50.66-300.5500
Investing Cash Flow
43.52-303.92-3.06-8.65
Share Issuance / Repurchase
0.11238.500
Debt Issued / Paid
-1.534.54-0.4-0.14
Other Financing Activities
00121.8125
Financing Cash Flow
-1.42243.04121.4224.86
Net Cash Flow
-2.85-96.5126.353.69
Free Cash Flow
-52.09-38.994.93-21.17
Free Cash Flow Margin
-232.76%-614.37%--
Free Cash Flow Per Share
-1.89-2.483.60-15.46
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).